GERN
Geron Corporation
NASDAQ: GERN · HEALTHCARE · BIOTECHNOLOGY
$1.54
+1.99% today
Updated 2026-04-30
Market cap
$980.58M
P/E ratio
—
P/S ratio
5.33x
EPS (TTM)
$-0.13
Dividend yield
—
52W range
$1 – $2
Volume
19.1M
Geron Corporation (GERN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-45.40%
Operating margin
-17.70%
ROE
-33.00%
ROA
-5.54%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $3.28M | $-31.36M | 100.00% | -1,445.22% | -957.13% |
| 2007 | $7.62M | $-36.70M | 100.00% | -824.44% | -481.46% |
| 2008 | $2.80M | $-62.02M | 100.00% | -2,391.87% | -2,212.67% |
| 2009 | $1.73M | $-70.18M | 100.00% | -4,069.18% | -4,066.28% |
| 2010 | $3.56M | $-111.38M | 100.00% | -3,120.04% | -3,125.93% |
| 2011 | $2.44M | $-96.85M | 100.00% | -3,942.41% | -3,972.64% |
| 2012 | $2.71M | $-68.88M | -829.42% | -2,648.87% | -2,542.67% |
| 2013 | $1.28M | $-38.38M | -611.93% | -3,036.48% | -2,991.35% |
| 2014 | $1.15M | $-35.67M | -671.99% | -3,149.35% | -3,093.67% |
| 2015 | $36.37M | $46000.00 | 73.68% | -1.54% | 0.13% |
| 2016 | $6.16M | $-29.54M | -138.48% | -497.34% | -479.34% |
| 2017 | $1.06M | $-27.92M | -692.21% | -2,746.95% | -2,621.22% |
| 2018 | $1.07M | $-27.02M | -1,093.53% | -2,914.92% | -2,534.43% |
| 2019 | $460000.00 | $-63.55M | 100.00% | -15,761.96% | -13,815.43% |
| 2020 | $253000.00 | $-75.62M | -19,683.40% | -30,400.40% | -29,888.14% |
| 2021 | $1.39M | $-116.11M | 100.00% | -8,183.70% | -8,335.39% |
| 2022 | $596000.00 | $-141.90M | 100.00% | -23,246.64% | -23,808.89% |
| 2023 | $237000.00 | $-184.13M | 100.00% | -81,832.91% | -77,690.72% |
| 2024 | $76.99M | $-174.57M | 98.37% | -225.64% | -226.73% |
| 2025 | $183.88M | $-85.78M | 97.42% | -29.28% | -46.65% |